NO972558L - Sett for osteoporose-behandlingssyklus - Google Patents

Sett for osteoporose-behandlingssyklus

Info

Publication number
NO972558L
NO972558L NO972558A NO972558A NO972558L NO 972558 L NO972558 L NO 972558L NO 972558 A NO972558 A NO 972558A NO 972558 A NO972558 A NO 972558A NO 972558 L NO972558 L NO 972558L
Authority
NO
Norway
Prior art keywords
treatment cycle
osteoporosis treatment
osteoporosis
solvate
kit
Prior art date
Application number
NO972558A
Other languages
English (en)
Norwegian (no)
Other versions
NO972558D0 (no
Inventor
Martine Gazard
Olivier Gros
Jacques Girard
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of NO972558D0 publication Critical patent/NO972558D0/no
Publication of NO972558L publication Critical patent/NO972558L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
NO972558A 1994-12-06 1997-06-05 Sett for osteoporose-behandlingssyklus NO972558L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9414630A FR2727629A1 (fr) 1994-12-06 1994-12-06 Trousse pour cycle de traitement de l'osteoporose
PCT/FR1995/001596 WO1996017616A1 (fr) 1994-12-06 1995-12-05 Trousse pour cycle de traitement de l'osteoporose

Publications (2)

Publication Number Publication Date
NO972558D0 NO972558D0 (no) 1997-06-05
NO972558L true NO972558L (no) 1997-08-05

Family

ID=9469504

Family Applications (1)

Application Number Title Priority Date Filing Date
NO972558A NO972558L (no) 1994-12-06 1997-06-05 Sett for osteoporose-behandlingssyklus

Country Status (20)

Country Link
EP (1) EP0797444A1 (fr)
JP (1) JPH10509729A (fr)
KR (1) KR980700083A (fr)
CN (1) CN1168634A (fr)
AR (1) AR002946A1 (fr)
AU (1) AU4307396A (fr)
BR (1) BR9509961A (fr)
CA (1) CA2207028A1 (fr)
CZ (1) CZ175397A3 (fr)
FI (1) FI972383L (fr)
FR (1) FR2727629A1 (fr)
HU (1) HUT77382A (fr)
IL (1) IL116168A0 (fr)
MA (1) MA23737A1 (fr)
NO (1) NO972558L (fr)
PL (1) PL320564A1 (fr)
SK (1) SK68597A3 (fr)
TR (1) TR199501530A1 (fr)
WO (1) WO1996017616A1 (fr)
ZA (1) ZA9510184B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5994329A (en) 1997-07-22 1999-11-30 Merck & Co., Inc. Method for inhibiting bone resorption
US6432932B1 (en) 1997-07-22 2002-08-13 Merck & Co., Inc. Method for inhibiting bone resorption
KR20060058151A (ko) 2002-05-10 2006-05-29 에프. 호프만-라 로슈 아게 골다공증 치료 및 예방용 비스포스폰산
ES2291749T5 (es) * 2002-12-20 2011-07-21 F. Hoffmann-La Roche Ag Formulación de altas dosis de ibandronato.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3583887D1 (de) * 1984-04-30 1991-10-02 Procter & Gamble Ausruestung fuer die behandlung der osteoporose.
US4761406A (en) * 1985-06-06 1988-08-02 The Procter & Gamble Company Regimen for treating osteoporosis
DK0648120T3 (da) * 1992-06-30 1998-01-19 Procter & Gamble Pharma Anvendelse af phosphonater til behandling af osteoporose
FR2694558B1 (fr) * 1992-08-05 1994-10-28 Sanofi Elf Monohydrate du sel disodique de l'acide 4-chlorophénylthiométhylène bisphosphonique, sa préparation, les compositions pharmaceutiques en contenant.

Also Published As

Publication number Publication date
MX9704105A (es) 1997-09-30
TR199501530A1 (tr) 1996-10-21
FR2727629B1 (fr) 1997-02-28
FI972383A0 (fi) 1997-06-05
KR980700083A (ko) 1998-03-30
CA2207028A1 (fr) 1996-06-13
CZ175397A3 (en) 1997-10-15
FI972383A7 (fi) 1997-06-05
AR002946A1 (es) 1998-05-27
SK68597A3 (en) 1997-11-05
MA23737A1 (fr) 1996-07-01
FI972383L (fi) 1997-06-05
NO972558D0 (no) 1997-06-05
PL320564A1 (en) 1997-10-13
BR9509961A (pt) 1997-11-25
AU4307396A (en) 1996-06-26
FR2727629A1 (fr) 1996-06-07
IL116168A0 (en) 1996-01-31
WO1996017616A1 (fr) 1996-06-13
CN1168634A (zh) 1997-12-24
EP0797444A1 (fr) 1997-10-01
ZA9510184B (en) 1996-06-11
JPH10509729A (ja) 1998-09-22
HUT77382A (hu) 1998-04-28

Similar Documents

Publication Publication Date Title
NL300224I1 (nl) 3-Benzazepinzonen gesubstitueerd met een benzocyclobutyl-of indanylalkyla-minoalkylgroep, bruikbaar voor de behandeling van cardiovasculaire aandoeningen.
IS4083A (is) Samsetning lyfjaefna, aðferð til framleiðslu hennar, og notkunar sem lyfja
DE69721766D1 (de) Neue arzneiformulierung
NO20092860L (no) 2, 6 dioksopiperidin samt farmasoytiske preparater som inneholder disse
NO307408B1 (no) Aminosukker og glykosaminglykansammensetning for behandling og reparasjon av bindevev
EP0209689A3 (en) Use of tetrahydrobiopterins in the treatment of infantile autism
DK0480934T3 (da) Lægemiddel, der indeholder ephedrin og koffein til behandling af overvægt
IS3703A7 (is) Aðferð til framleiðslu á efnasamsetningu til lækninga, sem er samverkandi og starfsmagnandi og aðferðir við notkun hennar
DK549189A (da) Galanthamin-analoge samt anvendelse af disse til fremstilling af laegemidler til behandling af alzheimer's syge
TW360544B (en) Analgestic and antiinflammatory fomentation pharmaceutical composition
NO305581B1 (no) Anvendelse av et benaktivt fosfonat i kombinasjon med et °strogenhormon, og preparat i enhetsdoseform for behandling av osteoporose
DE69614375D1 (de) Dermatologische zubereitung zur behandlung von aktinischen keratosen
DE69316013D1 (de) Verwendung von phosphinate zur behandlung der osteoporose
ATE131060T1 (de) Chenodeoxycholsäure oder ursodeoxycholsäure zur behandlung von erkrankungen der atmungsorgane.
NO155375C (no) Naturlig vev egnet for implantering i en levende kropp samt fremgangsmaate til aa redusere forkalkningen av naturlig vev som finner sted etter implanteringen i en levende kropp
NO972558L (no) Sett for osteoporose-behandlingssyklus
NZ326345A (en) Composition containing diosgenin
TR200000455T2 (tr) Alzheimer hastalığının tedavisinde fankinonun kullanılması.
NO962259L (no) Anvendelse av dimeticon for behandling av aphthae og stomatitt
GR3006674T3 (fr)
AU3108289A (en) Compositions comprising 24,25-dihydroxy-vitamin D3 and calcium for the treatment of osteoporosis in humans
ATE149840T1 (de) Behandlung von leberkrebs
NO961242D0 (no) Fremgangsmåte for fremstilling av faste dispersjoner og depoter såvel som faste medisinske former med dihydropyridin-type kalsium-antagonister
NO960347L (no) Anvendelse av benzydamid ved behandling av patologiske tilstander forårsaket av TNF
DK0546007T3 (da) Produkt, og anvendelse heraf til behandling af kataboliske tilstande, omfattende autentisk IGF-1 og hypokaloriske mængder af næringsmidler